Dr. Neil Kaye, Forensic Psychiatrist, has been recognized as a “Leader in Medicine” among “America’s Best Doctors” for 2017. He will be sharing his knowledge and expertise in the areas of General Psychiatry, Geriatric Psychiatry, Forensic Psychiatry, Neuropsychiatry and Psychopharmacology.
Dr. Kaye has been active in the healthcare industry for the past 32 years. His private practice focuses on forensic, adult, psychopharmacology, neuropsychiatry, geriatric psychiatry, and new drug research and clinical testing. He specializes in the diagnosis and management of complex psychiatric and neuropsychiatric conditions. He has over 30 years of experience doing clinical research, including evaluation and management of polypharmacy including drug-drug and drug-food interaction profiling, interpretation of chemical/lab results, cardiograms, genetic sampling, and ordering and interpretation of neuroimaging including CT, MRI, fMRI, SPECT, PET.
Dr. Kaye is a third generation physician and was inspired to follow in his father’s footsteps and pursue a career in Psychiatry. He received his MD from Albany Medical College in 1984 and completed his Residency at Albany Medical Center Hospital in 1987. He then completed a Fellowship in Law and Psychiatry at SUNY Upstate.
Dr. Kaye attributes his success to a strong work ethic, a passion for his work in the field of Psychiatry, and a belief in evidenced based practices. He has received numerous honors, including the Golden Apple for teaching, the Red Apple from the American Academy of Psychiatry and the Law and has been a 4-time winner of a Top Doctor Award from Delaware Today Magazine. His day-to-day responsibilities include the diagnosis and treatment of patients within all areas of Adult, Geriatric, and Forensic Psychiatry.
Dr. Kaye is the founder and past chairman of the Task Force on Psychopharmacology and the Law for the American Academy of Psychiatry and the Law, where has also served as a Councilor. He has delivered thousands of lectures in 49 states and internationally and has more than 60 peer-reviewed publications. He is a Past President of the Psychiatric Society of Delaware and currently sits on their Executive Council. He has been an advisor to numerous law enforcement and governmental agencies and remains active in promoting awareness of the interaction of mental health/substance abuse and behavior.
He has no plans of slowing down and expects to remain active clinically as well as legislatively to promote the appropriate care and treatment of people with mental illness and works diligently to break the stigma of mental illness.
Dr. Kaye is a member of the American Psychiatric Association, American Academy of Psychiatry and the Law, Brain Injury Association, and is triple Board Certified by the American Board of Psychiatry. He also is on the Advisory Board of the National Alliance on Mental Illness (Delaware) and the Brain Injury Association of Delaware.
In his free time, Dr. Kaye enjoys cooking, flying helicopters, cooking, and spending time with his wife Dr. Susan Donnelly.
Share this entry
Dr. Neil Kaye has been active in the healthcare industry for the past 32 years
- His private practice focuses on forensic, adult, psychopharmacology, neuropsychiatry, geriatric psychiatry, and new drug research and clinical testing
- He specializes in clinical research including polypharmacy interaction profiling, ocular screening, labs, cardiograms, genetic sampling, ordering and interpretation of CT, MRI, fMRI, SPECT, PET, and genetic profiles.
- Dr. Kaye is the founder and past chairman of the Task Force on Psychopharmacology and the Law.
- Dr. Kaye is a member of the American Psychiatric Association, American Academy of Psychiatry and the Law, Brain Injury Association, and American Board of Psychiatry. He also works with the National Alliance on Mental Illness.
- Effect of open-label lamotrigine as monotherapy and adjunctive therapy on the self-assessed cognitive function scores of patients with bipolar I disorder-2007. PubMed
- Is your depressed patient bipolar?2005-PubMed
- Patients/consumers vs. evidence-based medicine.2004-PubMed
- An open-label trial of donepezil (Aricept) in the treatment of persons with mild traumatic brain injury.2003-PubMed
- Psychic akathisia.2003-PubMed
- Ziprasidone augmentation of clozapine in 11 patients.2003-PubMed